Dupont Capital Management Corp purchased a new stake in National Health Investors, Inc. (NYSE:NHI – Get Rating) during the third quarter, according to its latest filing with the Securities and Exchange Commission. The firm bought 8,367 shares of the real estate investment fund, valued at approximately $473,000.
Several other hedge funds have also recently changed their holdings in the company. Truist Financial Corp acquired a new position in National Health Investors stock during the third quarter valued at $506,000. Janney Montgomery Scott LLC increased her position in National Health Investors stock by 0.9% during the third quarter. Janney Montgomery Scott LLC now owns 25,019 shares of the real estate investment fund valued at $1,414,000 after purchasing an additional 234 shares during the period. Financial Advantage Inc. acquired a new position in National Health Investors stock during the third quarter valued at $56,000. Raymond James & Associates increased its position in National Health Investors stock by 3.3% during the third quarter. Raymond James & Associates now owns 20,213 shares of the real estate investment fund valued at $1,143,000 after purchasing an additional 637 shares during the period. Finally, Raymond James Financial Services Advisors Inc. increased its position in National Health Investors stock by 4.7% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 6,327 shares of the real estate investment trust worth $358,000 after buying another 286 shares during the period. 62.44% of the stock is currently owned by institutional investors and hedge funds.
Wall Street analysts expect growth
Several stock analysts have recently released reports on the company. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Friday, Jan. 6. In a report on Friday, Dec. 9, Credit Suisse Group upgraded National Health Investors from an “underperforming” rating to a “neutral” rating and raised its price target for the stock from $47.00 to $58.00. Finally, Truist Financial cut National Health Investors price target from $64.00 to $61.00 and set a “hold” rating on the stock in a report on Monday, Sept. 26. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, National Health Investors currently has a consensus rating of “Hold” and a consensus price target of $61.25.
National Health Investors stock performance
Shares of NYSE NHI opened at $55.15 on Friday. The company has a rapid ratio of 13.83, a current ratio of 13.82, and a debt-to-equity ratio of 0.85. The stock has a market cap of $2.39 billion, a price/earnings ratio of 35.13, and a beta of 0.85. The stock’s fifty-day simple moving average is $54.71, and its 200-day simple moving average is $58.58. National Health Investors, Inc. has a 52-week low of $50.22 and a 52-week high of $67.16.
National Health Investors announces dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, January 27. Shareholders of record on Friday, December 30 will receive a $0.90 dividend. The ex-dividend date for this dividend is Thursday 29 December. This represents an annualized dividend of $3.60 and a dividend yield of 6.53%. National Health Investors’ Dividend Payout Ratio (DPR) is currently 229.30%.
Insider trading at National Health Investors
In other National Health Investors news, Director Robert G. Adams bought 1,000 shares of the company in a transaction dated Wednesday, Dec. 14. The stock was purchased at an average price of $56.60 per share, for a total value of $56,600.00. Following the completion of the transaction, the Administrator now directly owns 180,548 shares of the company, valued at approximately $10,219,016.80. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, available via this link. 7.26% of the shares are currently owned by insiders.
Domestic Healthcare Investor Information
(Get Rating)
Formed in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of senior housing and need-based and discretionary medical investments. NHI’s portfolio consists of independent, assisted living and memory care communities, fee-paying retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Read more
Want to see which other hedge funds hold NHI? Visit HoldingsChannel.com to get the latest 13F and insider trade filings for National Health Investors, Inc. (NYSE:NHI – Get Ratings).
This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider National Health Investors, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and best-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks top analysts are whispering to their clients to buy now before the broader market catches on… and National Health Investors wasn’t on the list.
While National Health Investors currently has a “Hold” rating among analysts, senior analysts believe these five stocks are better buys.
View the five titles here
